FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300773010> ?p ?o ?g. }

• W4300773010 abstract "Abstract Background Oral anticoagulation therapy with warfarin requires frequent monitoring level of anticoagulation by the international normalized ratio (INR). In Africa, studies that explore anticoagulation control, treatment outcomes, and associated factors are reported in various ways in long-term patients receiving warfarin therapy to generate concrete scientific evidence. Methods The literature search was conducted in PubMed, Cochrane Library, African Journal of Online databases, Google Scholar, and Google. An advanced search strategy was computed to retrieve relevant studies related to anticoagulation control and outcomes. Duplication, title and abstract screening, and full-text assessment were conducted in Covidence software. Study quality was assessed using the Joanna Briggs Institute Critical appraisal quality assessment tool. The systematic review is registered in PROSPERO (CRD42021260772) and performed based on the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guideline. Results Out of 298 identified articles, 18 articles were eligible for the final review and analysis. The mean of 39.4 ± 8.4% time in therapeutic range (TTR) (29.4 to 57.3%), 36.7 ± 11.5% TTR (range 25.2–49.7%) and 46% TTR (43.5–48.5%) was computed from studies that determined TTR by Rosendaal, direct and cross-section-of-the-files methods, respectively. In this review, the lowest percentage of TTR was 13.7%, while the highest was 57.3%. The highest percentage of patients (32.25%) who had TTR ≥ 65% was reported in Tunisia, but the lowest percentages were in Namibia (10%, TTR ≥ 65%) and Kenya (10.4%, TTR ≥ 70%). Most of the included studies (11 out of 18) used Rosendaal’s method while the direct method was employed by three studies. Generally, 10.4–32.3% of study participants achieved desired optimal anticoagulation level. Regarding secondary outcomes, 1.6–7.5% and 0.006–59% of patients experienced thromboembolic complications and bleeding events, respectively. Having chronic comorbidities, taking more than two drugs, and presence of medications that potentially interact with warfarin, and patient-related factors (patients aged < 50 years old, female gender, lower education level, smoking history) were the frequently reported predictors of poor anticoagulation therapy. Conclusions Oral anticoagulation control was suboptimal in patients taking warfarin as evidenced by low TTR in Africa. Therefore, there is an urgent need for further improving oral anticoagulation management services." @default.
• W4300773010 created "2022-10-04" @default.
• W4300773010 creator A5010519772 @default.
• W4300773010 creator A5037597828 @default.
• W4300773010 creator A5062135522 @default.
• W4300773010 creator A5063317279 @default.
• W4300773010 creator A5079738579 @default.
• W4300773010 date "2022-10-03" @default.
• W4300773010 modified "2023-10-02" @default.
• W4300773010 title "Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review" @default.
• W4300773010 cites W1585402525 @default.
• W4300773010 cites W1876074594 @default.
• W4300773010 cites W1965365924 @default.
• W4300773010 cites W1970294794 @default.
• W4300773010 cites W2018856451 @default.
• W4300773010 cites W2025440490 @default.
• W4300773010 cites W2030703473 @default.
• W4300773010 cites W205203474 @default.
• W4300773010 cites W2080546718 @default.
• W4300773010 cites W2096114203 @default.
• W4300773010 cites W2123257771 @default.
• W4300773010 cites W2124691949 @default.
• W4300773010 cites W2130176356 @default.
• W4300773010 cites W2145232618 @default.
• W4300773010 cites W2165832859 @default.
• W4300773010 cites W2268786988 @default.
• W4300773010 cites W2275653506 @default.
• W4300773010 cites W2333398915 @default.
• W4300773010 cites W2339161452 @default.
• W4300773010 cites W2410566890 @default.
• W4300773010 cites W2467324381 @default.
• W4300773010 cites W2528730946 @default.
• W4300773010 cites W2583679349 @default.
• W4300773010 cites W2616222093 @default.
• W4300773010 cites W2621766432 @default.
• W4300773010 cites W2765301147 @default.
• W4300773010 cites W2780382937 @default.
• W4300773010 cites W2800715615 @default.
• W4300773010 cites W2803436921 @default.
• W4300773010 cites W2888084884 @default.
• W4300773010 cites W2902217090 @default.
• W4300773010 cites W2911109092 @default.
• W4300773010 cites W2930750295 @default.
• W4300773010 cites W2941299840 @default.
• W4300773010 cites W2954968704 @default.
• W4300773010 cites W2998082560 @default.
• W4300773010 cites W2999783216 @default.
• W4300773010 cites W3003893050 @default.
• W4300773010 cites W3007312998 @default.
• W4300773010 cites W3007600240 @default.
• W4300773010 cites W3008544426 @default.
• W4300773010 cites W3012005423 @default.
• W4300773010 cites W3024313701 @default.
• W4300773010 cites W3038111536 @default.
• W4300773010 cites W3049082505 @default.
• W4300773010 cites W3082188176 @default.
• W4300773010 cites W3118615836 @default.
• W4300773010 cites W3131182013 @default.
• W4300773010 cites W3132271826 @default.
• W4300773010 cites W3133595432 @default.
• W4300773010 cites W3139088611 @default.
• W4300773010 cites W3148200954 @default.
• W4300773010 cites W3164620715 @default.
• W4300773010 cites W3200496060 @default.
• W4300773010 cites W3210628926 @default.
• W4300773010 cites W54365661 @default.
• W4300773010 cites W2308548576 @default.
• W4300773010 doi "https://doi.org/10.1186/s12959-022-00416-9" @default.
• W4300773010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36192776" @default.
• W4300773010 hasPublicationYear "2022" @default.
• W4300773010 type Work @default.
• W4300773010 citedByCount "1" @default.
• W4300773010 countsByYear W43007730102023 @default.
• W4300773010 crossrefType "journal-article" @default.
• W4300773010 hasAuthorship W4300773010A5010519772 @default.
• W4300773010 hasAuthorship W4300773010A5037597828 @default.
• W4300773010 hasAuthorship W4300773010A5062135522 @default.
• W4300773010 hasAuthorship W4300773010A5063317279 @default.
• W4300773010 hasAuthorship W4300773010A5079738579 @default.
• W4300773010 hasBestOaLocation W43007730101 @default.
• W4300773010 hasConcept C126322002 @default.
• W4300773010 hasConcept C142724271 @default.
• W4300773010 hasConcept C152541439 @default.
• W4300773010 hasConcept C17744445 @default.
• W4300773010 hasConcept C189708586 @default.
• W4300773010 hasConcept C199539241 @default.
• W4300773010 hasConcept C204787440 @default.
• W4300773010 hasConcept C2776301958 @default.
• W4300773010 hasConcept C2776478404 @default.
• W4300773010 hasConcept C2779161974 @default.
• W4300773010 hasConcept C2779473830 @default.
• W4300773010 hasConcept C2780182762 @default.
• W4300773010 hasConcept C512399662 @default.
• W4300773010 hasConcept C71924100 @default.
• W4300773010 hasConcept C95190672 @default.
• W4300773010 hasConceptScore W4300773010C126322002 @default.
• W4300773010 hasConceptScore W4300773010C142724271 @default.
• W4300773010 hasConceptScore W4300773010C152541439 @default.
• W4300773010 hasConceptScore W4300773010C17744445 @default.
• W4300773010 hasConceptScore W4300773010C189708586 @default.

• next